About this trial
Correlation Between Upper Cross Syndrome and Neck Proprioception
Hypothesis:
No statistically significant relationship exists between upper cross syndrome and neck proprioception.
Study Design:
Randomized Controlled Trial
Participants:
Office workers (≥4h computer use/day) Age: 28-48 years Chronic nonspecific neck pain (\>3 months) Forward head posture (FHP) \<46° VAS score: 3-8 cm No cognitive impairments affecting participation
Exclusion Criteria:
Systemic, rheumatic, or neuromuscular diseases Neurological signs, spinal surgery, or recent physical therapy Missing ≥3 consecutive or 4 nonconsecutive sessions
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
office workers (using a computer at least 4 h),
aged between 28 and 48 years,
NP between 3 and 8 cm on a visual analog scale (VAS) (from 0 indicating no pain at all to 10 indicating unbearable pain),
chronic nonspecific neck pain lasting for more than 3 months, and FHP less than 46° (Fathollahnejad et al., 2019).
Disqualifiers
specific causes of NP (e.g., systemic, rheumatic, neuromuscular diseases), central or peripheral neurological signs, cognitive impairment, spinal surgery, or physical therapy treatments in the last 6 months prior to the baseline assessment.
Participants would be also excluded if they missed at least three consecutive or four nonconsecutive sessions (Fathollahnejad et al., 2019).
Trial population
The study population consists of adult office workers with specific characteristics related to their occupation, posture, and neck pain history. Below is a detailed breakdown: Demographic Characteristics Age Range: 28-48 years. Gender: Not specified, but likely includes both males and females. Occupation: Office workers using computers for at least 4 hours daily. Clinical Characteristics Chronic Nonspecific Neck Pain (CNP): Pain lasting ≥3 months. Pain intensity between 3-8 cm on the Visual Analog Scale (VAS). Forward Head Posture (FHP): Measured angle of FHP is less than 46°. No Specific Diagnoses: Participants with neck pain due to systemic, rheumatic, or neuromuscular diseases are excluded.
Trial design
Cohort
Prospective
Treatments tested in this trial
Intervention Group
Other interventionGroup/Cohort Description: Participants with Upper Cross Syndrome (UCS) who undergo the prescribed exercise or treatment protocol.
Treatment groups
Trial outcomes
Primary outcomes
Cervical Proprioception:
Measurement Tool: CROM device. Tests: Neutral Head Position (NHP): Assesses participants' ability to actively reposition their head to a self-selected neutral position. Target Head Position (THP): Assesses ability to reposition the head to a previously demonstrated target position.
Secondary outcomes
Neck Pain
Measurement Tool: Visual Analog Scale (10-cm scale) Purpose: Evaluate participants' subjective pain levels before and after the intervention. Scale Range: 0 (no pain) to 10 (unbearable pain). Interpretation: Higher scores indicate worse pain levels.
Balance
Measurement Tool: Biodex Balance System. Parameters: Static and dynamic balance. Postural stability score (lower scores indicate better balance). Purpose: Explore the effect of UCS on overall balance and stability.
Neck Disability Index (NDI):
Measurement Tool: NDI questionnaire. Purpose: Assess the impact of neck pain on daily activities and functional limitations.
Cervical Range of Motion (CROM)
Measurement Tool: CROM device. Purpose: Measure the range of motion in the cervical spine to detect restrictions due to UCS.
Other outcomes
Spinal Curvature:
Measurement Tool: Spinal Mouse Device. Parameters: Sagittal plane alignment in neutral, flexion, and extension. Purpose: Assess structural changes or adaptations in the spine due to UCS.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: